Indoco Remedies Limited
Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
What Indoco files
- Others55
- Investor Meet40
- Important24
- Updates17
- Board Meeting6
- Dividend/Bonus4
Indoco Remedies' Goa sterile facility received 7 USFDA observations during a recent inspection. The company is actively addressing these findings and will respond to the USFDA. Investors should monitor progress on these operational issues.
Indoco Remedies sold a 2,876.08 sq meter plot of land to Kalpataru Townships for Rs. 64.00 Cr. This transaction is expected to have no impact on the company's core business operations.
Indoco Remedies significantly advanced sustainability in FY26. Renewable energy reached 43.5% of total consumption, with net Scope 1 & 2 GHG emissions down 8.8% and water withdrawal reduced by 16.7%. Its Patalganga API site achieved an EcoVadis Bronze rating. The company also converted a 107.50 Cr loan to a subsidiary...
Indoco Remedies completed the sale of its Ophthalmic Division across India and various African territories to Sunways (India) Private Limited. This divestment aims to streamline Indoco's business.
Indoco Remedies completed a sale and leaseback with OPC Asset Solution. It sold movable assets for Rs. 24.65 Cr and leased them back for Rs. 34.89 Cr over ten years. This move provides capital without impacting the company's manufacturing or business operations.